Sun Pharma Appoints Deloitte Haskins & Sells as Statutory Auditors
Sun Pharmaceutical Industries Ltd 路 Outcome 路 30 Oct 2026, 8:47 pm
Sun Pharma Appoints Deloitte Haskins & Sells as Statutory Auditors Sun Pharmaceutical Industries approved the appointment of Deloitte Haskins & Sells Chartered Accountants LLP as statutory auditors for a five-year term, subject to shareholder approval. The mandate begins from the conclusion of the FY27 AGM and runs until the FY32 AGM. Deloitte replaces incumbent auditor S R B C & CO LLP, which completes its mandatory two consecutive five-year terms at the FY27 AGM in compliance with Section 139(2) of the Companies Act, 2013.
Original exchange filing (PDF)
More announcements from Sun Pharmaceutical Industries Ltd
- Intimation of Schedule of Analyst/Institutional Investor Meeting 路 05 Nov 2026
- Q2FY27 Earnings Call Transcript 路 05 Nov 2026
- Clarification regarding news report relating to the Company''s Assam facility 路 03 Nov 2026
- The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on November 2, 2026, with reference to news appeared in https://www.thehindu.com/ dated October 30, 2026 quoting .... 路 02 Nov 2026
- Completion and results of postal ballot dated 01 October 2026 路 01 Nov 2026
- Q2FY27- Investor Call Audio Recording 路 31 Oct 2026
- Unaudited Financial Results for the quarter and half year ended 30 September 2026 路 30 Oct 2026
- Unaudited Financial Results for the quarter and half year ended 30 September 2026 路 30 Oct 2026
